InvestorsHub Logo
Followers 17
Posts 900
Boards Moderated 0
Alias Born 09/28/2014

Re: None

Wednesday, 06/17/2020 8:01:12 AM

Wednesday, June 17, 2020 8:01:12 AM

Post# of 704183
Of interest:

Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Providing large scale manufacturing capacity for AZD1222
KEELE, United Kingdom, June 16, 2020 /PRNewswire/ — Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has signed a supply agreement with AstraZeneca UK Ltd. (“AstraZeneca”) to provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222, previously known as ChAdOx1 n-CoV-19. The production agreement is part of AstraZeneca’s recently announced in-licensed programme with the University of Oxford to ensure broad and equitable supply of the vaccine throughout the world, at no profit during the COVID-19 pandemic.

https://www.cognatebioservices.com/cobra-biologics-signs-supply-agreement-with-astrazeneca-for-manufacture-of-covid-19-vaccine-candidate/


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News